The Department of Health of Abu Dhabi is advancing precision medicine for Alzheimer’s disease by incorporating APOE E4 genotyping into its pharmacogenomics (PGx) reports. This initiative, in collaboration with M42’s Biogenix Lab, aims to enhance treatment customization based on individual genetic profiles. The updated PGx reports will enable healthcare providers to tailor treatments according to...
